Allergic Rhinitis - Alcon Laboratories (UK) Ltd Withdraws Its Application To Extend The Marketing Authorisation For Opatanol

... The European Medicines Agency was formally notified by Alcon Laboratories (UK) Ltd of its decision to withdraw its application for an extension of the marketing authorisation for the medicinal product Opatanol (Olopatadine hydrochloride). Opatanol was first authorised in the European Union on 17 May 2002 as eye drops for the treatment of ocular signs and symptoms of seasonal allergic conjunctivitis... click link for more info. ...